← All stocks

Evolus, Inc.

EOLS Net selling
CIK 0001570562 #3025 in the set updated 17 Sep 2026
Bought (120 mo)
$53.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$287.88M
$3.91M on a plan · $4.22M straight out of an exercise
Sold at will
$279.75M
69 of 97 sales
Net
−$233.94M
−$225.81M against sales at will

By person

21 insiders · 142 transactions
5.8×

David Moatazedi holds 5.8 times base salary in stock. $4.52M of shares against $775.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David Moatazedi last reported holding, valued at $9.04, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
AEON Biopharma, Inc. entity
Former 10% Owner
$190.83M (7)
−$190.83M
0
$0.00
−100.0%
Alphaeon 1 LLC entity
10% owner
$40.22M (2)
−$40.22M
10,279,742
$92.91M
−30.2%
Medytox Inc. entity
Former 10% Owner
$8.06M (15)
$33.81M (10)
−$25.75M
10,640,826
$96.18M
−24.1%
Malik Vikram
Director
$26.65M (4)
$2.09M (7)
+$24.56M
1,464,810
$13.24M
+6,659%
MOATAZEDI DAVID
See Remarks
$16.48M (29)
−$16.48M
499,592
$4.52M
BLANK SIMONE
Director
$16.41M (3)
+$16.41M
927,471
$8.38M
Avelar Rui
See Remarks
$1.91M (15)
−$1.91M
427,423
$3.86M
+326.5%
Romine Kristine
Director
$1.54M (11)
+$1.54M
84,359
$762.48K
SILVERNAIL LAUREN P
See Remarks
$1.19M (6)
−$1.19M
141,571
$1.28M
Beaver Sandra
Chief Financial Officer
$437.75K (9) scheduled
−$437.75K
167,089
$1.51M
Parschauer Karah Herdman
Director
$324.20K (2)
−$324.20K
77,742
$702.67K
Hau Bosun
Director
$309.73K (2)
+$309.73K
10,040
$90.75K
Jafar Michael M.
See Remarks
$266.59K (1)
$20.13K (1)
+$246.46K
219,851
$1.99M
+109,826%
Stewart Brady
Director
$204.49K (1)
+$204.49K
134,188
$1.21M
GILL DAVID N
Director
$65.60K (2)
$268.67K (4)
−$203.07K
86,887
$785.33K
Yamagishi-Dressler Tomoko
Chief Marketing Officer
$192.35K (3) scheduled
−$192.35K
89,949
$813.00K
White Albert G III
Director
$189.00K (1)
+$189.00K
95,937
$867.13K
HAYMAN ROBERT
Director
$153.86K (3)
+$153.86K
65,222
$589.51K
+197,542%
Muilenburg Crystal
Chief Marketing Officer
$123.11K (2)
−$123.11K
134,248
$1.21M
+57.2%
FARRELL PETER C
Director
$91.05K (1)
+$91.05K
53,174
$480.61K
Mitchell Tatjana
Chief Financial Officer
226,092
$2.04M

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
MOATAZEDI DAVID
6 Jun 2024
See Remarks
Sold after exercise
175,940
$12.59
$2.21M
MOATAZEDI DAVID
5 Jun 2024
See Remarks
Sold after exercise
155,278
$12.92
$2.01M

What was left out

Form 4 filings counted 224
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 2
Sales at will 69
Transactions with no price 0
Shares from compensation/vesting 15,064,534
Sales filed before the plan box existed 47
History held since 13 Feb 2018